{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:57:35Z","timestamp":1771001855310,"version":"3.50.1"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBAP11ZJFA_001"],"award-info":[{"award-number":["RBAP11ZJFA_001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008501","name":"East Carolina University","doi-asserted-by":"publisher","award":["111104"],"award-info":[{"award-number":["111104"]}],"id":[{"id":"10.13039\/100008501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jbior.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T11:49:10Z","timestamp":1476100150000},"page":"32-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis"],"prefix":"10.1016","volume":"63","author":[{"given":"James A.","family":"McCubrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kvin","family":"Lertpiriyapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto M.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Rakus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Gizak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melchiorre","family":"Cervello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiseppe","family":"Montalto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li V.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Steelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbior.2016.10.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2014.09.013","article-title":"MicroRNA and cancer\u2013a brief overview","volume":"57","author":"Acunzo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbior.2015.11.002","article-title":"Investigating the effect of arachidonate supplementation on the phosphoinositide content of MCF10a breast epithelial cells","volume":"62","author":"Anderson","year":"2016","journal-title":"Adv. Biol. Regul."},{"issue":"4","key":"10.1016\/j.jbior.2016.10.001_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/15384101.2016.1138183","article-title":"A\u00a0PTEN inhibitor displays preclinical activity against hepatocarcinoma cells","volume":"15","author":"Augello","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2016.10.001_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jbior.2015.05.001","article-title":"Implication of PI3K\/Akt pathway in pancreatic cancer: when PI3K isoforms matter?","volume":"59","author":"Baer","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbior.2016.05.001","article-title":"Gene regulation in the immediate-early response process","volume":"62","author":"Bahrami","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/13894501113149990194","article-title":"MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance","volume":"15","author":"Barone","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jbior.2016.10.001_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/1078-0432.CCR-15-1522","article-title":"SAR405838: a novel and potent inhibitor of the MDM2:p53 Axis for the treatment of dedifferentiated liposarcoma","volume":"22","author":"Bill","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/co500026b","article-title":"Fragment-based library generation for the discovery of a peptidomimetic p53-Mdm4 inhibitor","volume":"16","author":"Boltjes","year":"2014","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.jbior.2016.10.001_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","article-title":"p53-mediated activation of miRNA34 candidate tumor-suppressor genes","volume":"17","author":"Bommer","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","article-title":"A\u00a0single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans","volume":"119","author":"Bond","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/emboj.2010.349","article-title":"The ZEB1\/miR-200 feedback loop controls Notch signalling in cancer cells","volume":"30","author":"Brabletz","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jbior.2016.10.001_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jbior.2014.11.003","article-title":"NGF and ProNGF: regulation of neuronal and neoplastic responses through receptor signaling","volume":"58","author":"Bradshaw","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib14","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1158\/0008-5472.CAN-08-1569","article-title":"p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest","volume":"68","author":"Braun","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib15","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1038\/sj.onc.1210531","article-title":"The p53\u2013Mdm2\u2013HAUSP complex is involved in p53 stabilization by HAUSP","volume":"26","author":"Brooks","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/1947601910377491","article-title":"Myc: maestro of microRNAs","volume":"1","author":"Bui","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A\u00a0reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells","volume":"9","author":"Burk","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbior.2016.10.001_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A\u00a0reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells","volume":"9","author":"Burk","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbior.2016.10.001_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib20","article-title":"Rab11 and phosphoinositides: a synergy of signal transducers in the control of vesicular trafficking","author":"Campa","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.bjc.6605199","article-title":"MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53","volume":"101","author":"Canner","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1158\/1535-7163.MCT-05-0356","article-title":"Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2","volume":"5","author":"Cao","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2016.10.001_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbior.2014.11.001","article-title":"Sphingolipids in the DNA damage response","volume":"58","author":"Carroll","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2009-03-212563","article-title":"Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML","volume":"115","author":"Carter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2016.10.001_bib25","doi-asserted-by":"crossref","first-page":"30487","DOI":"10.18632\/oncotarget.5890","article-title":"Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells","volume":"6","author":"Carter","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jbior.2016.10.001_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncb2173","article-title":"p53 regulates epithelial mesenchymal transition and stem cell properties through modulating miRNAs","volume":"13","author":"Chang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib28","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4161\/cc.22852","article-title":"p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3","volume":"11","author":"Chappell","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2016.10.001_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbior.2015.10.001","article-title":"Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells","volume":"60","author":"Chappell","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2016.10.001_bib31","doi-asserted-by":"crossref","first-page":"e109578","DOI":"10.1371\/journal.pone.0109578","article-title":"Histone deacetylase 1\/Sp1\/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2016.10.001_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1158\/1541-7786.MCR-07-0161","article-title":"Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin induced apoptosis: a potent drug combination","volume":"5","author":"Cheok","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib33","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/cdd.2010.18","article-title":"Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53","volume":"17","author":"Cheok","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbior.2016.10.001_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbior.2015.10.004","article-title":"IQGAP1 is a phosphoinositide effector and kinase scaffold","volume":"60","author":"Choi","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ncb2366","article-title":"miR-34 miRNAs provide a barrier for somatic cell reprogramming","volume":"13","author":"Choi","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00280-015-2791-y","article-title":"In\u00a0vitro cytotoxicity and in\u00a0vivo efficacy, pharmacokinetics, and metabolism of pyrazole-based small molecule inhibitors of Mdm2\/4-p53 interaction","volume":"76","author":"Christner","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jbior.2016.10.001_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/cdd.2009.109","article-title":"p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC","volume":"17","author":"Christoffersen","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbior.2016.10.001_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature03117","article-title":"Regulation of p53 activity through lysine methylation","volume":"432","author":"Chuikov","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2016.10.001_bib40","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2005-08-3273","article-title":"MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells","volume":"107","author":"Coll-Mulet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2016.10.001_bib41","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.biocel.2013.04.015","article-title":"Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells","volume":"45","author":"Dai","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2274","article-title":"The interplay between MYC and HIF in cancer","volume":"8","author":"Dang","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib43","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.18632\/oncotarget.4433","article-title":"The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer","volume":"8","author":"Deben","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2016.03.017","article-title":"APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines","volume":"375","author":"Deben","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbior.2016.10.001_bib45","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1158\/0008-5472.CAN-06-0537","article-title":"Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing","volume":"66","author":"Diederichs","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib46","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1073\/pnas.1405663111","article-title":"Phosphatases reverse p53-mediated cell cycle checkpoints","volume":"111","author":"Donehowerm","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2016.10.001_bib47","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1038\/onc.2012.334","article-title":"Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis","volume":"32","author":"Dong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/leu.2008.348","article-title":"Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma","volume":"23","author":"Drakos","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2016.10.001_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jbior.2014.09.014","article-title":"PLC\u025b mediated sustained signaling pathways","volume":"57","author":"Dusaban","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/humu.22524","article-title":"The Mdm network and its regulation of p53 activities: a rheostat of cancer risk","volume":"35","author":"Eischen","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jbior.2016.10.001_bib51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.09.057","article-title":"Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors","volume":"155","author":"Emerling","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbior.2015.10.003","article-title":"Role of the lysophosphatidylinositol\/GPR55 axis in cancer","volume":"60","author":"Falasca","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","article-title":"Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance","volume":"9","author":"Fantin","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2010.03.004","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Feng","year":"2010","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib55","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK \u03b21, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1\u2013AKT\u2013mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.biopha.2012.06.002","article-title":"Review of miR-200b and cancer chemosensitivity","volume":"66","author":"Feng","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbior.2016.10.001_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2013.11.004","article-title":"MiR-200, a new star miRNA in human cancer","volume":"344","author":"Feng","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbior.2016.10.001_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jbior.2015.10.009","article-title":"The chromosome 3q26 On Cassette: a multigenic driver of human cancer","volume":"60","author":"Fields","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib59","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2016.10.001_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jbior.2015.06.003","article-title":"Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells","volume":"59","author":"Fitzgerald","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jbior.2014.10.004","article-title":"PLC and PI3K\/Akt\/mTOR signalling in disease and cancer","volume":"57","author":"Follo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jbior.2015.11.008","article-title":"The role of class I, II and III PI 3-kinases in platelet production and activation and their implication in thrombosis","volume":"61","author":"Gaits-Iacovoni","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jbior.2015.11.007","article-title":"Phosphatidylinositol 5-phosphate 4-kinase \u03b3 (PI5P4K\u03b3), a lipid signalling enigma","volume":"61","author":"Giudici","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib64","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lfs.2015.12.047","article-title":"Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins by in silico approaches and binding assay","volume":"145","author":"Golestanian","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.jbior.2016.10.001_bib65","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc3318","article-title":"MicroRNAs in the p53 network: micromanagement of tumour suppression","volume":"12","author":"Hermeking","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib68","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.biocel.2010.06.011","article-title":"Regulation of the p53 pathway by ubiquitin and related proteins","volume":"42","author":"Hock","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib69","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/emboj.2011.419","article-title":"Regulation of p53 stability and function by the deubiquitinating enzyme USP42","volume":"30","author":"Hock","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jbior.2016.10.001_bib70","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2010.05.027","article-title":"Negative regulation of tumor suppressor p53 by microRNA miR-504","volume":"38","author":"Hu","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1947601912454734","article-title":"The regulation of multiple p53 Stress responses is mediated through MDM2","volume":"3","author":"Hu","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbior.2014.09.008","article-title":"Sphingolipids in pulmonary fibrosis","volume":"57","author":"Huang","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib73","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.1102309108","article-title":"The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in\u00a0vivo","volume":"108","author":"Huang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2016.10.001_bib74","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.18632\/oncotarget.3052","article-title":"The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy","volume":"6","author":"Humphries","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib75","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/mol.109.063321","article-title":"MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells","volume":"77","author":"Ichimura","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbior.2016.10.001_bib76","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbagrm.2014.04.003","article-title":"MicroRNAs as regulators and mediators of c-MYC function","volume":"1849","author":"Jackstadt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2016.10.001_bib77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbior.2014.09.004","article-title":"Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes","volume":"57","author":"Jhanwar-Uniyal","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib78","doi-asserted-by":"crossref","first-page":"e6816","DOI":"10.1371\/journal.pone.0006816","article-title":"MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells","volume":"4","author":"Ji","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2016.10.001_bib79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib80","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1097-2765(01)00349-5","article-title":"Involvement of PIAS1 in the sumoylation of tumor suppressor p53","volume":"8","author":"Kahyo","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib81","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010462","article-title":"Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis","volume":"10","author":"Kaller","year":"2011","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.jbior.2016.10.001_bib82","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1535-7163.MCT-15-0467","article-title":"Identification of a small molecule that overcomes HdmX-mediated suppression of p53","volume":"15","author":"Karan","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2016.10.001_bib83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrd4236","article-title":"Drugging the p53 pathway: understanding the route to clinical efficacy","volume":"13","author":"Khoo","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbior.2016.10.001_bib84","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.20110235","article-title":"p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2","volume":"208","author":"Kim","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.201103097","article-title":"A\u00a0p53\/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition","volume":"195","author":"Kim","year":"2011","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib86","doi-asserted-by":"crossref","first-page":"ra71","DOI":"10.1126\/scisignal.2001744","article-title":"p53 and microRNA-34 are suppressors of canonical Wnt signaling","volume":"4","author":"Kim","year":"2011","journal-title":"Sci. Signal"},{"key":"10.1016\/j.jbior.2016.10.001_bib87","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/onc.2015.48","article-title":"Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential","volume":"34","author":"Knezevic","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/cdd.2010.94","article-title":"Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells","volume":"18","author":"Kogan-Sakin","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbior.2016.10.001_bib89","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.4161\/cc.5.23.3520","article-title":"Concomitant inhibition of MDM2 and Bcl-2 protein function synergistically induce mitochondrial apoptosis in AML","volume":"5","author":"Kojima","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2016.10.001_bib90","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood-2008-01-128611","article-title":"Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia","volume":"112","author":"Kojima","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2016.10.001_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.18632\/oncotarget.1427","article-title":"The proto-oncogene KRAS is targeted by miR-200c","volume":"5","author":"Kopp","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib92","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2016.10.001_bib93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/cdd.2012.155","article-title":"A\u00a0threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis","volume":"20","author":"Kracikova","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbior.2016.10.001_bib94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2015.12.002","article-title":"p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E\/K) BRAF melanoma to vemurafenib","volume":"55","author":"Krayem","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib95","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.molcel.2011.01.023","article-title":"The MK5\/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis","volume":"41","author":"Kress","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jbior.2015.05.002","article-title":"Class I PI 3-kinases: function and evolution","volume":"59","author":"Kriplani","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib97","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1101\/gr.077578.108","article-title":"In-depth characterization of the microRNA transcriptome in a leukemia progression model","volume":"18","author":"Kuchenbauer","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib98","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/onc.2010.457","article-title":"Negative regulation of the tumor suppressor p53 gene by microRNAs","volume":"30","author":"Kumar","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib99","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ccr.2009.03.003","article-title":"PRIMA-1 reactivates mutant p53 by covalent binding to the core domain","volume":"15","author":"Lambert","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib100","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1101\/gad.1767609","article-title":"MicroRNA-125b is a novel negative regulator of p53","volume":"23","author":"Le","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2016.10.001_bib101","first-page":"9","article-title":"Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis","volume":"2","author":"Leaderer","year":"2011","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"10.1016\/j.jbior.2016.10.001_bib102","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bcp.2013.01.032","article-title":"Discovery of a new small-molecule inhibitor of p53\u2013MDM2 interaction using a yeast based approach","volume":"85","author":"Le\u00e3o","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbior.2016.10.001_bib103","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4161\/cc.6.5.3901","article-title":"A\u00a0dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells","volume":"6","author":"Lehmann","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2016.10.001_bib104","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1200\/JCO.2011.40.7783","article-title":"Targeting p53 in\u00a0vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer","volume":"30","author":"Lehmann","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jbior.2016.10.001_bib105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/ERC-10-0148","article-title":"The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients","volume":"18","author":"Leskel\u00e4","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib106","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ncomms1519","article-title":"Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity","volume":"2","author":"Leveille","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbior.2016.10.001_bib107","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1038\/sj.onc.1209334","article-title":"Protein serine\/threonine.-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities","volume":"25","author":"Li","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib108","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib109","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2011.02.003","article-title":"miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression","volume":"304","author":"Li","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbior.2016.10.001_bib110","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1742-4658.2011.08075.x","article-title":"The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"278","author":"Li","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.jbior.2016.10.001_bib111","doi-asserted-by":"crossref","first-page":"14026","DOI":"10.18632\/oncotarget.4334","article-title":"Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R\/STAT3\/miR-34a feed-back loop","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib112","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/bjc.2014.181","article-title":"Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer","volume":"110","author":"Lin","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib113","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/0008-5472.CAN-14-0683","article-title":"FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX","volume":"74","author":"Ling","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib114","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib115","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1007\/s13277-014-2521-9","article-title":"MicroRNA-191 promotes pancreatic cancer progression by targeting USP10","volume":"35","author":"Liu","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib116","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2010-01-261628","article-title":"Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia","volume":"116","author":"Long","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2016.10.001_bib117","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/db07-1252","article-title":"Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction","volume":"57","author":"Lovis","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jbior.2016.10.001_bib118","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1101\/gad.1291305","article-title":"PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints","volume":"19","author":"Lu","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2016.10.001_bib119","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccr.2007.08.033","article-title":"The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop","volume":"12","author":"Lu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ccr.2013.03.013","article-title":"Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1, CDK1-phosphorylated nuclear iASPP","volume":"23","author":"Lu","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib121","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cbf.3015","article-title":"Phospholipase C \u025b-1 inhibits p53 expression in lung cancer","volume":"32","author":"Luo","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.jbior.2016.10.001_bib122","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jbior.2015.06.002","article-title":"PI3K signaling in arterial diseases: non redundant functions of the PI3K isoforms","volume":"59","author":"Lupieri","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib123","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nsmb1306","article-title":"The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP","volume":"14","author":"Mantovani","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib124","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cell.2010.05.017","article-title":"A\u00a0MicroRNA targeting dicer for metastasis control","volume":"141","author":"Martello","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib125","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/leu.2011.315","article-title":"Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia","volume":"26","author":"McCormack","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2016.10.001_bib126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jbior.2014.09.016","article-title":"Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis","volume":"57","author":"McCubrey","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib127","doi-asserted-by":"crossref","first-page":"831","DOI":"10.15252\/emmm.201404396","article-title":"ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat","volume":"7","author":"Meidhof","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng.317","article-title":"A\u00a0TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function","volume":"41","author":"Melo","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbior.2016.10.001_bib129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ccr.2010.09.007","article-title":"A\u00a0genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells","volume":"18","author":"Melo","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canep.2014.01.003","article-title":"Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients","volume":"38","author":"Men","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.jbior.2016.10.001_bib131","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1056\/NEJMoa0803785","article-title":"Dicer, Drosha, and outcomes in patients with ovarian cancer","volume":"359","author":"Merritt","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib132","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/0008-5472.CAN-08-1856","article-title":"Reversal of P-glycoproteinmediated multidrug resistance by the murine double minute 2 antagonist nutlin-3","volume":"69","author":"Michaelis","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib133","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/ijc.27832","article-title":"Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells","volume":"132","author":"Mir","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib134","doi-asserted-by":"crossref","first-page":"e1794","DOI":"10.1038\/cddis.2015.143","article-title":"APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells","volume":"6","author":"Mohell","year":"2015","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.jbior.2016.10.001_bib135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jbior.2014.10.003","article-title":"Lipid rafts as major platforms for signaling regulation in cancer","volume":"57","author":"Mollinedo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib136","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","article-title":"The MDM2 gene amplification database","volume":"26","author":"Momand","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jbior.2015.11.011","article-title":"Membrane and inhibitor interactions of intracellular phospholipases A2","volume":"61","author":"Mouchlis","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib138","first-page":"2228","article-title":"Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53","volume":"63","author":"Nesslinger","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib139","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbior.2015.10.005","article-title":"Localizing the lipid products of PI3K\u03b3 in neutrophils","volume":"60","author":"Norton","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib140","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbior.2016.10.001_bib141","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/cncr.27837","article-title":"Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma","volume":"119","author":"Ohnstad","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib142","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/cncr.27837","article-title":"Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma","volume":"119","author":"Ohnstad","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib143","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2016.10.001_bib144","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nsmb.1533","article-title":"miR-29 miRNAs activate p53 by targeting p85\u03b1 and CDC42","volume":"16","author":"Park","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-09-0971","article-title":"SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2","volume":"9","author":"Peck","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2016.10.001_bib147","doi-asserted-by":"crossref","first-page":"228","DOI":"10.18632\/oncotarget.443","article-title":"Regulation of p53: a collaboration between mdm2 and mdmx","volume":"3","author":"Pei","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib148","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.20041502","article-title":"Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope","volume":"201","author":"Perfettini","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib149","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccr.2010.09.005","article-title":"Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53\/MDM2 autoregulatory loop in multiple myeloma development","volume":"18","author":"Pichiorri","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib150","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/ijc.29642","article-title":"A\u00a0self-enforcing CD44s\/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells","volume":"137","author":"Preca","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib151","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbior.2015.09.001","article-title":"Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation","volume":"60","author":"Pyne","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib152","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molcel.2014.02.020","article-title":"Inositol pyrophosphates mediate the DNA-PK\/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1\/Tel2","volume":"54","author":"Rao","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib153","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","article-title":"Effect of the MDM2 antagonist RG7112 on the p53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study","volume":"13","author":"Ray-Coquard","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbior.2016.10.001_bib154","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.yexcr.2006.04.021","article-title":"(R)-roscovitine (CYC202, seliciclib) sensitizes SH-SY5Y neuroblastoma cells to nutlin-3-induced apoptosis","volume":"312","author":"Ribas","year":"2006","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mc.20795","article-title":"Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells","volume":"51","author":"Rigatti","year":"2012","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jbior.2016.10.001_bib156","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib157","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/onc.2010.382","article-title":"PRIMA-1(MET)\/APR-246 targets mutant forms of p53 family members p63 and p73","volume":"29","author":"Rokaeus","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib158","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jmcb\/mju003","article-title":"The p53\/miR-34 axis in development and disease","volume":"6","author":"Rokavec","year":"2014","journal-title":"J.\u00a0Mol. Cell. Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib159","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4161\/cbt.10.6.12535","article-title":"Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways","volume":"10","author":"Saha","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jbior.2016.10.001_bib160","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.18632\/oncotarget.3116","article-title":"Identifying the determinants of response to MDM2 inhibition","volume":"6","author":"Saiki","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib161","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jbior.2015.10.007","article-title":"CHK1 and replicative stress in T-cell leukemia: can an irreverent tumor suppressor end up playing the oncogene?","volume":"60","author":"Sarmento","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib162","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cvr\/cvr103","article-title":"IQGAP1 regulates ERK1\/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload","volume":"91","author":"Sbroggi\u00f2","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib163","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2015.11.006","article-title":"Phospholipase C\u03b2 connects G protein signaling with RNA interference","volume":"61","author":"Scarlata","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib164","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jbior.2014.09.006","article-title":"The Ras\/Rap GTPase activating protein RASA3: from gene structure to in\u00a0vivo functions","volume":"57","author":"Schurmans","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2016.03.001","article-title":"Specific expression and function of inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) in wild type and knock-out mice","volume":"62","author":"Scoumanne","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib166","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1182\/blood-2005-11-4465","article-title":"Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Secchiero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2016.10.001_bib167","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1593\/neo.07523","article-title":"The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts","volume":"9","author":"Secchiero","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbior.2016.10.001_bib168","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.1201753109","article-title":"Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246\/PRIMA-1MET","volume":"110","author":"Shalom-Feuerstein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2016.10.001_bib169","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes","volume":"57","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jbior.2014.09.015","article-title":"Inositol pyrophosphates: why so many phosphates?","volume":"57","author":"Shears","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib171","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1073\/pnas.1201993110","article-title":"APR-246\/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations","volume":"110","author":"Shen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2016.10.001_bib172","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib173","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2012.02.113","article-title":"Structural insights into the dualtargeting mechanism of Nutlin-3","volume":"420","author":"Shin","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbior.2016.10.001_bib174","first-page":"847","article-title":"Negative regulators of tumor suppress p53 in the context of anticancer therapy","volume":"57","author":"Shuvalov","year":"2015","journal-title":"Tsitologiia"},{"key":"10.1016\/j.jbior.2016.10.001_bib175","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/emmm.201302827","article-title":"The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance","volume":"5","author":"Siebzehnrubl","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib176","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.4161\/cc.10.24.18552","article-title":"miR-34 and SNAIL form a double negative feedback loop to regulate epithelial mesenchymal transitions","volume":"10","author":"Siemens","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2016.10.001_bib177","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbior.2014.09.002","article-title":"Regulation of de novo sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1","volume":"57","author":"Siow","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib178","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jbior.2014.09.012","article-title":"PTEN inhibitors: an evaluation of current compounds","volume":"57","author":"Spinelli","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib179","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1016\/j.jbior.2016.10.001_bib180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/emboj.2011.434","article-title":"Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1","volume":"31","author":"Sun","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.jbior.2016.10.001_bib181","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1535-7163.MCT-07-0442","article-title":"Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53","volume":"7","author":"Supiot","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2016.10.001_bib182","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Suzuki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2016.10.001_bib183","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/nm.2227","article-title":"miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma","volume":"16","author":"Swarbrick","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbior.2016.10.001_bib184","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/1078-0432.CCR-08-0399","article-title":"MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma","volume":"15","author":"Tabe","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2015.09.009","article-title":"Reciprocal regulation of p53 and NF-\u03baB by diacylglycerol kinase \u03b6","volume":"60","author":"Tanaka","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib186","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2011.09.029","article-title":"Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","volume":"147","author":"Tay","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib187","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbrc.2010.04.112","article-title":"MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3\u2032 untranslated region","volume":"396","author":"Tian","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbior.2016.10.001_bib188","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/1535-7163.MCT-15-0237","article-title":"Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model","volume":"14","author":"Tonsing-Carter","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbior.2016.10.001_bib189","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.jcim.5b00747","article-title":"An effective virtual screening protocol to identify promising p53-MDM2 inhibitors","volume":"56","author":"Tortorella","year":"2016","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jbior.2016.10.001_bib190","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-12-2807","article-title":"MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models","volume":"73","author":"Tovar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib191","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1535-6108(03)00022-9","article-title":"PTEN and p53: who will get the upper hand?","volume":"3","author":"Trotman","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib192","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/emboj.2011.124","article-title":"Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53","volume":"30","author":"Ugalde","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jbior.2016.10.001_bib193","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbior.2015.09.003","article-title":"Inositol pyrophosphates modulate cell cycle independently of alteration in telomere length","volume":"60","author":"Valet","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib194","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jbior.2015.11.008","article-title":"The role of class I, II and III PI 3-kinases in platelet production and activation and their implication in thrombosis","volume":"61","author":"Valet","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0065-230X(09)02005-3","article-title":"Sirtuins and p53","volume":"102","author":"van Leeuwen","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib196","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jnci\/djp355","article-title":"Antitumor activity of the selective MDM2 antagonist nutlin-3 Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53","volume":"101","author":"Van Maerken","year":"2009","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.jbior.2016.10.001_bib197","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In\u00a0vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jbior.2016.10.001_bib198","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bcp.2009.09.020","article-title":"DNA damage response to the Mdm2 inhibitor nutlin-3","volume":"79","author":"Verma","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbior.2016.10.001_bib199","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/sj.onc.1209246","article-title":"The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7","volume":"25","author":"Vinall","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2016.10.001_bib200","first-page":"914","article-title":"Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression","volume":"5","author":"Vinall","year":"2012","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.jbior.2016.10.001_bib201","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.2174\/0929867311320210007","article-title":"Nanoparticles loaded with Nutlin-3 display cytotoxicity towards p53(wild-type) JVM-2 but not towards p53(mutated) BJAB leukemic cells","volume":"20","author":"Voltan","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jbior.2016.10.001_bib202","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.18632\/oncotarget.4091","article-title":"Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: nanoparticle preparation, characterization, in\u00a0vitro and in\u00a0vivo anti-prostate cancer activity, and mechanisms of action","volume":"6","author":"Voruganti","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib203","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbior.2016.10.001_bib204","first-page":"151","article-title":"Small-molecule inhibitors of the p53-MDM2 interaction","volume":"348","author":"Vu","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jbior.2016.10.001_bib205","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/ml4000657","article-title":"Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development","volume":"4","author":"Vu","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbior.2016.10.001_bib206","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.4161\/cc.7.13.6072","article-title":"BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death","volume":"7","author":"Wade","year":"2008","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.jbior.2016.10.001_bib225","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.2174\/092986711798194388","article-title":"Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy","volume":"18","author":"Wei","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jbior.2016.10.001_bib207","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ncb1998","article-title":"The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs","volume":"11","author":"Wellner","year":"2009","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.jbior.2016.10.001_bib208","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbrc.2009.11.093","article-title":"miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion","volume":"391","author":"Xia","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbior.2016.10.001_bib209","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/emboj.2010.347","article-title":"miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress","volume":"30","author":"Xiao","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jbior.2016.10.001_bib210","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2009.02.038","article-title":"MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib211","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2016.10.001_bib213","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jbior.2015.11.003","article-title":"Primary phospholipase C and brain disorders","volume":"61","author":"Yang","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2016.10.001_bib214","doi-asserted-by":"crossref","first-page":"14517","DOI":"10.1073\/pnas.96.25.14517","article-title":"Identification and classification of p53-regulated genes","volume":"96","author":"Yu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2016.10.001_bib215","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","article-title":"USP10 regulates p53 localization and stability by deubiquitinating p53","volume":"140","author":"Yuan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2016.10.001_bib216","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-8722-4-16","article-title":"Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP","volume":"4","author":"Yuan","year":"2011","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.jbior.2016.10.001_bib217","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3892\/ijo.2014.2644","article-title":"P-Akt\/miR-200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells","volume":"45","author":"Yuan","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbior.2016.10.001_bib218","first-page":"411","article-title":"PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53","volume":"30","author":"Zache","year":"2008","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.jbior.2016.10.001_bib219","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-10-3168","article-title":"PRIMA-1Met\/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53","volume":"17","author":"Zandi","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib220","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9499","article-title":"Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer","author":"Zanjirband","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib221","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1158\/0008-5472.CAN-09-0878","article-title":"Blockade of mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase and murine double minute synergistically induces apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2016.10.001_bib222","doi-asserted-by":"crossref","first-page":"28949","DOI":"10.18632\/oncotarget.5027","article-title":"Loss of miR-200b promotes invasion via activating the Kindlin-2\/integrin beta1\/AKT pathway in esophageal squamous cell carcinoma: an E-cadherin-independent mechanism","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib223","article-title":"Targeting cancer stem cells with p53 modulators","volume":"2016","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2016.10.001_bib224","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-011-1752-3","article-title":"miR-200bc\/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP","volume":"69","author":"Zhu","year":"2012","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492616300550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492616300550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:53:33Z","timestamp":1762606413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492616300550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":221,"alternative-id":["S2212492616300550"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2016.10.001","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}